Skip to main content
. Author manuscript; available in PMC: 2008 Apr 30.
Published in final edited form as: Arch Gen Psychiatry. 2007 May;64(5):543–552. doi: 10.1001/archpsyc.64.5.543

Table 6.

Twelve-month use of appropriate medication among respondents with DSM-IV/CIDI bipolar disorder (BPD)1

Any BPD BP-I BP-II Sub-threshold BPD
% (se) % (se) % (se) % (se) χ2
I. Twelve-month cases
A. Psychiatrist
 Appropriate medication 45.0 (6.4) 41.6 (10.1) 45.1 (11.1) 51.5 (14.5) 1.0
 Other medication 43.4 (6.9) 51.7 (10.9) 39.9 (11.2) 32.7 (14.2) 8.0*
 No medication 11.6 (4.8) 6.7 (4.9) 14.9 (9.5) 15.8 (10.2) 1.7
   (n) (59) (27) (20) (12)
B. General medical (not including those treated by a psychiatrist)
 Appropriate medication 9.0* (4.2) 0.0* (0.0) 3.5* (3.8) 15.0* (7.6) 4.0
 Other medication 73.1* (6.3) 70.9 (17.5) 89.2 (7.8) 62.4 (9.2) 7.4*
 No medication 17.9 (4.8) 29.1 (17.5) 7.3 (6.8) 22.6 (7.9) 0.6
   (n) (52) (8) (16) (28)
C. Total1
 Appropriate medication 13.9 (2.4) 25.0 (6.8) 15.4 (4.1) 8.1 (2.5) 8.5*
 Other medication 31.4 (2.6) 38.7 (6.6) 38.9 (5.4) 23.8 (3.6) 5.3
 No medication 54.7 (3.0) 36.3 (6.1) 45.7 (4.0) 68.1 (4.7) 14.6*
   (n) (262) (65) (74) (123)
II. Lifetime cases (excluding 12-month cases)2
A. Psychiatrist
 Appropriate medication 41.1 (13.1) 46.7 (13.9) 28.4 (17.1) 48.9 (25.7) 0.9
 Other medication 43.3 (12.9) 32.0 (13.2) 52.4 (18.3) 51.1 (25.7) 2.7
 No medication 15.6 (7.7) 21.3 (14.1) 19.2 (12.9) 0.0 (0.0) 3.6
   (n) (23) (10) (8) (5)
B. General medical (not including those treated by a psychiatrist)
 Appropriate medication 6.9* (6.7) 0.0* (0.0) 42.7 (30.9) 0.0* (0.0) 1.2
 Other medication 65.6 (12.7) 43.0 (24.6) 40.8 (30.5) 84.9 (10.9) 2.4
 No medication 27.4 (11.5) 57.0 (24.6) 16.5 (16.9) 15.1 (10.9) 2.6
   (n) (17) (6) (3) (8)
C. Total1
 Appropriate medication 8.8 (2.8) 17.9 (5.7) 15.6 (8.2) 3.2 (1.9) 9.8*
 Other medication 25.1 (3.8) 35.3 (7.8) 24.5 (8.8) 21.5 (4.8) 1.9
 No medication 66.1 (3.6) 46.8 (7.1) 59.9 (10.0) 75.3 (4.9) 8.5*
   (n) (154) (36) (31) (87)
*

Significant difference across the three BPD subgroups at the .05 level, two-sided test

1

The denominator for C in both Part I and Part I includes cases not in treatment. The proportion with appropriate medication in C exceeds the sum of the weighted proportions in A and B due to the fact that some respondents reported use of appropriate medications even though they reported not having seen either a psychiatrist or a general medical professional at any time in the past 12 months.

2

Part II presents data on 12-month maintenance medication among lifetime cases who reported not having an episode of either mania/hypomania or MDE in the past 12 months.